vaccine tests on French volunteers will begin in a few days

On Wednesday evening, Inserm announced that it has reached agreements with three pharmaceutical companies looking for testers in France. Rehearsals will begin in mid-December.

© Provided by Franceinfo

In recent weeks, the French research agency Inserm has received the registrations of 41,000 volunteers ready to receive the first coronavirus vaccine projects before their commercialization to evaluate their efficacy and tolerance in humans. The results of these tests in France will add to those already obtained by manufacturers in the rest of the world.

Among the three laboratories that have entered into an agreement with Inserm, there are AstraZeneca. 1,000 French volunteers will test his vaccine project. The trial is expected to begin within ten days at the same time as another trial on the Janssen vaccine project, this time, including 1,000 French participants. Janssen begins his stage 3 test, the last.

Each time, the volunteers will be given the vaccine project or a placebo. They will live normally and researchers will observe if they are infected with Covid, if they have a severe form of the disease and if they are suffering from adverse effects. “There is immediate surveillance after vaccination and then we see the participants again. And then there is a more prolonged surveillance that lasts from one to two years, where we ask the participants to inform us of all the events that are happening to them. arrived “, explains Professor Odile Launay, who coordinates this French vaccination platform.

A third trial should begin within a month, with most volunteers over the age of 70. They will test the American vaccine project Modern. The goal is to find out if the product protects the elderly as much as others.

ALSO ON MSN – The distant reality of a health union

The distant reality of a health union

Click here to enlarge

NEXT VIDEO